Gene amplification or overexpression of the protein encoded by the erb‐B2 receptor tyrosine kinase 2 (ERBB2) gene, human epidermal growth factor receptor 2 (HER2), is associated with aggressive growth and poor clinical outcomes in a variety of cancers, including breast, ovarian, and gastric.1, 2. Here, ERBB2 is linked to cancer.